Mental Health DailyResearch. Evidence. Perspective.Published research on escitalopram.
In 148 stroke patients with depression, slow and normal CYP2C19 metabolizers had similar escitalopram response and remission after 8 weeks. Stroke disability predicted outcomes better than g…
Read articleDepression is a multifaceted mental health condition that presents significant challenges in both diagnosis and treatment. Recent studies have explored the potential of electroencephalograph…
Read articleMajor Depressive Disorder (MDD) significantly alters the brain’s network connectivity, with disturbances in the default mode network (DMN), salience network (SN), and dorsal attention networ…
Read articleDepression, a complex and often debilitating mental health condition, affects millions globally. Despite advances in psychiatric medicine, finding the right treatment remains a challenge for…
Read articleLexapro (escitalopram) and Prozac (fluoxetine) are two medications within the selective-serotonin reuptake inhibitors (SSRI) classification that are commonly administered for the treatment o…
Read articleCelexa (citalopram) and Lexapro (escitalopram) are chemically-analogous medications within the selective-serotonin reuptake inhibitor (SSRI) classification that are regularly prescribed for …
Read articleLexapro (escitalopram) and Zoloft (sertraline) are medications of the selective-serotonin reuptake inhibitor (SSRI) classification utilized most commonly for the management of major depressi…
Read article
